Yifeng Pharmacy Chain Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Retailing
  • ISIN: CNE100001TS5
CNY
24.45
-0.22 (-0.89%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

8.97 M

Shareholding (Jun 2024)

FII

0.00%

Held by 1 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Flat results in Sep 25

  • OPERATING CASH FLOW(Y) Lowest at CNY 3,241.23 MM
  • INVENTORY TURNOVER RATIO(HY) Lowest at 3.58 times
  • INTEREST COVERAGE RATIO(Q) Lowest at 1,152.32
2

With ROE of 16.03%, it has a very attractive valuation with a 2.75 Price to Book Value

3

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Retailing

stock-summary
Market cap

CNY 29,578 Million (Large Cap)

stock-summary
P/E

17.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.38%

stock-summary
Debt Equity

0.05

stock-summary
Return on Equity

16.34%

stock-summary
Price to Book

2.70

Revenue and Profits:
Net Sales:
5,564 Million
(Quarterly Results - Sep 2025)
Net Profit:
375 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
10.73%
0%
10.73%
6 Months
-3.97%
0%
-3.97%
1 Year
-1.73%
0%
-1.73%
2 Years
-28.14%
0%
-28.14%
3 Years
-27.78%
0%
-27.78%
4 Years
-2.89%
0%
-2.89%
5 Years
-40.07%
0%
-40.07%

Yifeng Pharmacy Chain Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
14.39%
EBIT Growth (5y)
17.10%
EBIT to Interest (avg)
10.65
Debt to EBITDA (avg)
0.49
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
1.25
Tax Ratio
23.99%
Dividend Payout Ratio
51.46%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
16.58%
ROE (avg)
14.86%

Valuation key factors

Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
2.75
EV to EBIT
13.62
EV to EBITDA
7.08
EV to Capital Employed
2.61
EV to Sales
1.30
PEG Ratio
NA
Dividend Yield
3.18%
ROCE (Latest)
19.15%
ROE (Latest)
16.03%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 1.97% vs 5.31% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 10.97% vs 2.70% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,564.10",
          "val2": "5,456.50",
          "chgp": "1.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "479.00",
          "val2": "1,012.90",
          "chgp": "-52.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "41.60",
          "val2": "56.90",
          "chgp": "-26.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "375.40",
          "val2": "338.30",
          "chgp": "10.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "86.10%",
          "val2": "82.10%",
          "chgp": "0.40%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 6.66% vs 13.54% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 4.55% vs 11.07% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "23,996.60",
          "val2": "22,498.80",
          "chgp": "6.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,369.00",
          "val2": "3,841.60",
          "chgp": "13.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "246.60",
          "val2": "179.50",
          "chgp": "37.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-18.30",
          "val2": "-12.60",
          "chgp": "-45.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,652.80",
          "val2": "1,580.90",
          "chgp": "4.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "92.60%",
          "val2": "89.30%",
          "chgp": "0.33%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary

Sep'25
Sep'24
Change(%)
Net Sales
5,564.10
5,456.50
1.97%
Operating Profit (PBDIT) excl Other Income
479.00
1,012.90
-52.71%
Interest
41.60
56.90
-26.89%
Exceptional Items
0.00
0.00
Consolidate Net Profit
375.40
338.30
10.97%
Operating Profit Margin (Excl OI)
86.10%
82.10%
0.40%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is 1.97% vs 5.31% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 10.97% vs 2.70% in Sep 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
23,996.60
22,498.80
6.66%
Operating Profit (PBDIT) excl Other Income
4,369.00
3,841.60
13.73%
Interest
246.60
179.50
37.38%
Exceptional Items
-18.30
-12.60
-45.24%
Consolidate Net Profit
1,652.80
1,580.90
4.55%
Operating Profit Margin (Excl OI)
92.60%
89.30%
0.33%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 6.66% vs 13.54% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 4.55% vs 11.07% in Dec 2023

stock-summaryCompany CV
About Yifeng Pharmacy Chain Co., Ltd. stock-summary
stock-summary
Yifeng Pharmacy Chain Co., Ltd.
Retailing
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available